John T. Treace, Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 296,372 shares at $18.00 ($5.3M) on 2021-11-24, disclosed to the SEC on 2021-11-24.
Open-market sale of $5.3M TMCI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.34 | 52,354 | $960K | 18.2% |
| 2 | $18.34 | 52,354 | $960K | 18.2% |
| 3 | $19.11 | 646 | $12K | 0.2% |
| 4 | $17.37 | 53,275 | $925K | 17.5% |
| 5 | $17.37 | 53,275 | $925K | 17.5% |
| 6 | $18.00 | 2,725 |
| $49K |
| 0.9% |
| 7 | $17.66 | 25,743 | $455K | 8.6% |
| 8 | $17.66 | 25,743 | $455K | 8.6% |
| 9 | $18.00 | 30,257 | $545K | 10.3% |
| Total | $17.84 avg | 296,372 | $5.3M | 100% |
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |